Home » Stocks » ALZN » Statistics

Alzamend Neuro, Inc. (ALZN)

Stock Price: $4.42 USD -0.49 (-9.98%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
After-hours: $4.45 +0.03 (0.68%) Jul 27, 5:18 PM

Total Valuation

Alzamend Neuro has a market cap or net worth of $363.60 million. The enterprise value is $364.72 million.

Market Cap 363.60M
Enterprise Value 364.72M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Alzamend Neuro has 82.26 million shares outstanding.

Shares Outstanding 82.26M
Share Change (YoY) n/a
Share Change (QoQ) +15.45%
Owned by Insiders (%) 40.23%
Owned by Institutions (%) 6.12%
Float 37.11M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio 0.38
Quick Ratio -7.07
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) -1,103.83%
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 1
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a
Taxes as % of Revenue n/a

Stock Price Statistics

Beta (1Y) n/a
Total Price Change -57.56%
50-Day Moving Average 7.68
200-Day Moving Average 7.68
Average Volume (30 Days) 4,284,127

Short Selling Information

The latest short interest is 153,510, so 0.19% of the outstanding shares have been sold short.

Short Interest 153,510
Short % of Shares Out 0.19%
Short Ratio (days to cover) 0.05

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Net Income -5.05M
Net Income Common n/a
EBIT n/a
Earnings Per Share (EPS) -$0.06
Full Income Statement

Balance Sheet

The company has $40,737 in cash and $1.16 million in debt, giving a net cash position of -$1.12 million or -$0.01 per share.

Cash & Cash Equivalents 40,737
Total Debt 1.16M
Net Cash -1.12M
Net Cash Per Share -$0.01
Book Value -1.30M
Book Value Per Share -0.02
Working Capital -1.30M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Alzamend Neuro does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -1.39%
FCF Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a